Shopping Cart
- Remove All
- Your shopping cart is currently empty
ERGi-USU-6 (mesylate) is a new selective ERG-positive prostate cancer inhibitor, with an IC50 of 0.089 μM, and is a salt derivative of ERGi-USU-6.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,110 | 10-14 weeks | |
50 mg | $1,450 | 10-14 weeks | |
100 mg | $2,320 | 10-14 weeks |
Description | ERGi-USU-6 (mesylate) is a new selective ERG-positive prostate cancer inhibitor, with an IC50 of 0.089 μM, and is a salt derivative of ERGi-USU-6. |
Molecular Weight | 338.38 |
Formula | C14H18N4O4S |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.